DKBmed Radio

Dr. Paul Auwaerter discusses the COVID-19 Delta variant. Topics: *Where and why the Delta variant is spreading *Do we need vaccine booster doses to protect against variants? *Treatments: oral antiviralmolnupiravirand steroids *Data on vaccine effectiveness against the Delta variantPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/7-28-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Paul Auwaerter answers your COVID-19 questions. Topics: *Can you tell if a patient has the Delta variant? *Expectations for the flu this year *Explaining questions of remdesivir efficacy *What if a patient misses a mRNA vaccine dose?Post-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/7-28-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of Medicine

Drs. Stella Safo and Dinora Chinchilla discuss ways we can address the COVID-19 health outcome disparities. Topics:*Real COVID-19 patient stories*COVID-19 health outcomes based on ethnicity and socioeconomic status*How social determinants of health determine COVID-19 risk*How to better treat minority patientsPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/7-16-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresenting faculty:Stella Safo, MD, MPHJust EquityForHealth, Founder and Executive Director, Assistant Professor Mount Sinai Health SystemDinora Chinchilla, MD Health Sciences Assistant Clinical Professor, UC Irvine Department of Pulmonary Critical Care, UC Irvine School of Medicine

Dr. Paul Auwaerter discusses the COVID-19Deltavariant. Topics: *How dangerous is theDeltavariant *Mutations that make theDeltavariant concerning *Does mRNA immunization impact fertility? *Is ivermectin an effective COVID-19 treatment? *Monoclonal antibodies that are effective against theDeltavariantPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/7-7-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of Medicine

Drs. David Klimpl and Paul Auwaerter discuss the latest recommendations and guidelines for treating COVID-19 patients in and out of the hospital. Topics: *NEW: monoclonal antibody treatment and recommendations for both ambulatory and hospitalized patients *Best practices for managing patients with COVID-19 *Test your knowledge with patient cases!Post-test for CME/CE credit:https://covid19.dkbmed.com/hospitalists/6-30-21-session/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresenting faculty: Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine at Johns Hopkins University School of MedicineDavid Klimpl, MDAssistant Professor, University of Colorado Denver - AnschultzMedical Campus, Denver, CO

Dr. Paul Auwaerter gives us an update COVID-19 treatments. Topics: *Monoclonal antibodiesfor hospitalized patients*MoredataonJAK inhibitors:tofacitinibandbaricitinib*Keeping vaccines updated with variants *Oxford University investigation of ivermectinPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/6-25-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Paul Auwaerter continues his interview with Dr. Patrick Flume about COVID-19 vaccine trials. Topics: *The challenges of studying a novel virus *Why are COVID-19 vaccine trials so long? *Tips for retaining vaccine trial participants *Determining vaccine safetyPost-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-23-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of MedicinePatrick Flume, MDProfessor of Medicine and Pediatrics, The Medical University of South CarolinaPowers-Huggins Endowed Chair for Cystic Fibrosis in Charleston, South Carolina

Drs.Charles Vega andAima A.Ahonkhadiscussways we can address the COVID-19 health outcome disparities. Topics:Real COVID-19 patient storiesCOVID-19 health outcomes based on ethnicity and socioeconomic statusHow social determinants of health determine COVID-19 riskTreating hospitalized and ambulatory patientsPost-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-18-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Charles Vega, MD, FAAFPHealth Sciences Clinical ProfessorUC Irvine Department of Family MedicineAssistant Dean for Culture and Community EducationUC Irvine School of MedicineDirector, UC Irvine Program in Medical Education for the Latino CommunityIrvine, CAAima A.Ahonkhai, MD, MPHAssistant Professor of MedicineDivision of Infectious DiseasesVanderbilt University Medical Center

Dr. Paul Auwaerter interviews Dr. Patrick Flume about COVID-19 vaccine trials. Topics: *Vaccine trial goals: preventing symptomatic COVID-19 vs preventing infection *Issues with comparing vaccine trials *The importance of recruiting a representative population (age, sex, race and ethnicity) *What do we know about vaccine safety for immunocompromised people?Post-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-11-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of MedicinePatrick Flume, MDProfessor of Medicine and Pediatrics, The Medical University of South CarolinaPowers-Huggins Endowed Chair for Cystic Fibrosis in Charleston, South Carolina